
Oritaz 4.5 Injection
Marketer
Apikos Pharma
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Oritaz 4.5 Injection
Oritaz 4.5 Injection combines two antibiotics to combat diverse bacterial infections by eliminating the infectious microorganisms. Administered exclusively by a medical professional, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the infection's severity and should be followed precisely. Always adhere to your doctor's prescribed usage. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions such as pain, swelling, or inflammation. Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions; adjustments to dosage or alternative medication may be necessary. While generally safe under medical guidance, its use during pregnancy and breastfeeding requires physician oversight.
Uses of Oritaz 4.5 Injection
Infections caused by bacteria
Major Benefits of Oritaz 4.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Oritaz 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Oritaz 4.5 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Oritaz 4.5 Injection works:
Oritaz 4.5 Injection blends Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. The addition of Tazobactum counters bacterial resistance, thus bolstering Piperacillin's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Oritaz 4.5 Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The administration of Oritaz 4.5 Injection during pregnancy is typically regarded as safe. Preclinical trials using animals have indicated minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactating individuals may safely administer Oritaz 4.5 Injection. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Oritaz 4.5 Injection on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with impaired kidney function should use Oritaz 4.5 Injection cautiously. The prescribed dosage of Oritaz 4.5 Injection may require modification. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Oritaz 4.5 Injection in patients with liver disease appears to present a low risk. Available evidence indicates dose modification may be unnecessary for this population. Physician consultation is advised.
What if you forget to take Oritaz 4.5 Injection :
Should you forget a dose of Oritaz 4.5 Injection, seek medical advice.
Facts to Know About Oritaz 4.5 Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Antimicrobial agents |
